As of August 2026, Newron Pharmaceuticals SpA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Newron Pharmaceuticals SpA. Stock Analysis NWPHF
United States Health Care Small Cap
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The firm undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Its additional projects, such as HF0220 for neuroprotection, NW-3509 for the treatment of schizophrenia, as well as pruvanserin and sarizotan for treatment of CNS diseases, are at various stages of preclinical and clinical development.
Newron Pharmaceuticals SpA (NWPHF) Chart
Financial Metrics & Statements of Newron Pharmaceuticals SpA (NWPHF)
FAQ's for Newron Pharmaceuticals SpA (NWPHF)
As of August 2026, Newron Pharmaceuticals SpA NWPHF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Newron Pharmaceuticals SpA using these criteria to determine its compliance status.
Muslim investors may consider investing in Newron Pharmaceuticals SpA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Newron Pharmaceuticals SpA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Newron Pharmaceuticals SpA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Newron Pharmaceuticals SpA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Newron Pharmaceuticals SpA (NWPHF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.